Q/C Technologies, Inc. (QCLS) ownership: Premas Biotech PVT Ltd. 55% · institutions 12% · index and ETF funds 0% (13F 2026-03-31). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Private Advisor Group, LLC | 333826.00 | $1.33M | 4.1% | 2026-03-31 |
| Quinn Opportunity Partners LLC | 211390.00 | $729296.00 | 2.6% | 2026-03-31 |
| Jane Street | 126188.00 | $435348.00 | 1.5% | 2026-03-31 |
| UBS | 77989.00 | $269062.00 | 1.0% | 2026-03-31 |
| Vanguard | 53066.00 | $183078.00 | 0.6% | 2026-03-31 |
| ADAR1 Capital Management, LLC | 50000.00 | $172500.00 | 0.6% | 2026-03-31 |
| Geode Capital Management | 47390.00 | $163495.00 | 0.6% | 2026-03-31 |
| Virtu Financial | 35380.00 | $141000.00 | 0.4% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-03-30 |
Back to QCLS overview · QCLS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.